S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities

Advent Technologies (ADN) Stock Forecast, Price & News

$0.70
-0.03 (-4.09%)
(As of 06/9/2023 ET)
Compare
Today's Range
$0.69
$0.77
50-Day Range
$0.62
$1.09
52-Week Range
$0.60
$4.48
Volume
644,133 shs
Average Volume
464,522 shs
Market Capitalization
$36.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.50

Advent Technologies MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
1,393.8% Upside
$10.50 Price Target
Short Interest
Bearish
5.16% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.20) to $0.60 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.05 out of 5 stars

Industrial Products Sector

138th out of 176 stocks

Miscellaneous Electrical Machinery, Equipment, & Supplies Industry

17th out of 25 stocks


ADN stock logo

About Advent Technologies (NASDAQ:ADN) Stock

Advent Technologies Holdings, Inc., an advanced materials and technology development company, operates in the fuel cell and hydrogen technology markets in North America, Europe, and Asia. It develops, manufactures, and assembles fuel cell systems and critical components that determine the performance of hydrogen fuel cells and other energy systems. The company offers high-temperature proton exchange membrane (HT-PEM) fuel cells, including membrane electrode assemblies, bipolar plates, and reformers, as well as provides fuel-cell stack assembly and testing services. It serves stationary power, portable power, automotive, aviation, energy storage, and sensor markets. The company is headquartered in Boston, Massachusetts.

Receive ADN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advent Technologies and its competitors with MarketBeat's FREE daily newsletter.

ADN Stock News Headlines

[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"
The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. Get the name of the stock here >>>
Advent Technologies (NASDAQ:ADN) Releases Earnings Results
Advent Technologies Reports Q1 2023 Results
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Why Advent Technologies Shares Are Gaining Today
See More Headlines

ADN Price History

ADN Company Calendar

Last Earnings
3/31/2023
Today
6/10/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Miscellaneous electrical machinery, equipment, & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:ADN
Fax
N/A
Employees
175
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$10.50
High Stock Price Forecast
$17.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+1,393.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-74,340,000.00
Net Margins
-1,087.97%
Pretax Margin
-1,094.81%

Debt

Sales & Book Value

Annual Sales
$7.84 million
Book Value
$1.24 per share

Miscellaneous

Free Float
38,674,000
Market Cap
$36.73 million
Optionable
Optionable
Beta
-0.07

Key Executives

  • Dr. Vassilios Gregoriou Ph.D. (Age 58)
    CEO & Chairman
    Comp: $800k
  • Mr. Kevin L. Brackman (Age 50)
    Chief Financial Officer
    Comp: $375k
  • Mr. James F. Coffey J.D. (Age 60)
    COO, Gen. Counsel & Corp. Sec.
    Comp: $475k
  • Dr. Emory Sayre De Castro Ph.D. (Age 65)
    CTO & Exec. Director
  • Dr. Christos Kaskavelis Ph.D. (Age 55)
    Chief Marketing Officer
  • Dr. Panoraia Gourdoupi Ph.D. (Age 44)
    Sr. VP of Corp. Bus. Devel. - Advent Technologies SA & Director
  • Mr. Naiem Hussain
    Chief Investment Officer
  • Mr. Alan Kneisz
    VP of Sales & Marketing
  • Mr. Morten Hougaard Sorensen
    Sr. VP
  • Mr. Daniel Hennig
    Sr. VP













ADN Stock - Frequently Asked Questions

Should I buy or sell Advent Technologies stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Advent Technologies in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ADN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ADN, but not buy additional shares or sell existing shares.
View ADN analyst ratings
or view top-rated stocks.

What is Advent Technologies' stock price forecast for 2023?

1 equities research analysts have issued 12 month target prices for Advent Technologies' stock. Their ADN share price forecasts range from $4.00 to $17.00. On average, they predict the company's share price to reach $10.50 in the next twelve months. This suggests a possible upside of 1,393.8% from the stock's current price.
View analysts price targets for ADN
or view top-rated stocks among Wall Street analysts.

How have ADN shares performed in 2023?

Advent Technologies' stock was trading at $1.81 at the beginning of the year. Since then, ADN shares have decreased by 61.2% and is now trading at $0.7029.
View the best growth stocks for 2023 here
.

When is Advent Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our ADN earnings forecast
.

How were Advent Technologies' earnings last quarter?

Advent Technologies Holdings, Inc. (NASDAQ:ADN) announced its earnings results on Friday, March, 31st. The company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.03) by $0.23. The business had revenue of $1.96 million for the quarter. Advent Technologies had a negative net margin of 1,087.97% and a negative trailing twelve-month return on equity of 54.61%.

What ETFs hold Advent Technologies' stock?
What is Advent Technologies' stock symbol?

Advent Technologies trades on the NASDAQ under the ticker symbol "ADN."

Who are Advent Technologies' major shareholders?

Advent Technologies' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (1.24%), Renaissance Technologies LLC (0.72%), Penserra Capital Management LLC (0.71%), Mirae Asset Global Investments Co. Ltd. (0.70%), Van ECK Associates Corp (0.39%) and Susquehanna International Group LLP (0.00%).

How do I buy shares of Advent Technologies?

Shares of ADN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Advent Technologies' stock price today?

One share of ADN stock can currently be purchased for approximately $0.70.

How much money does Advent Technologies make?

Advent Technologies (NASDAQ:ADN) has a market capitalization of $36.73 million and generates $7.84 million in revenue each year. The company earns $-74,340,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis.

How many employees does Advent Technologies have?

The company employs 175 workers across the globe.

How can I contact Advent Technologies?

Advent Technologies' mailing address is 1501 Ligonier Street Suite 370, Latrobe PA, 15650. The official website for the company is www.advent.energy. The company can be reached via phone at (617) 655-6000 or via email at ir@advent.energy.

This page (NASDAQ:ADN) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -